SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 374.27-0.2%Nov 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Haim R. Branisteanu
pak73
Pogeu Mahone
To: Haim R. Branisteanu who wrote (183391)2/1/2022 7:06:54 AM
From: THE ANT3 Recommendations  Read Replies (2) of 217988
 
Fasn inhibitors and add Lithium

FASN inhibitor TVB-2640 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as paclitaxel and trastuzumab, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Allocation: Non-Randomized
Estimated Enrollment : 80 participants
Intervention Model: Parallel Assignment
Study Type : Interventional (Clinical Trial)

FASN Inhibitor TVB-2640, Paclitaxel, and Trastuzumab in Treating …


clinicaltrials.gov/ct2/show/NCT03179904

An essential role for the tumor suppressor Merlin in regulating fatty acid synthesis (aacrjournals.org)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext